The Covid cash cow – a look at the Covid vaccine sales figures
pharmaphorum
NOVEMBER 19, 2021
Two casualties of the Pfizer/BioNTech and Moderna success, however, have been Sanofi and CureVac, both firms dropping their mRNA shots. Disappointing late-stage trials of CureVac’s jab meant there was no competitive advantage, while Sanofi said the dominance of current vaccines made penetration in the market difficult.
137 
Let's personalize your content